Skip to main content
. 2019 May 8;13(6):1342–1355. doi: 10.1002/1878-0261.12489

Figure 3.

Figure 3

Expression validation of DElncRNAs using qRT‐PCR in cohort of 52 early‐stage breast cancer samples (A) Heatmap of differentially regulated lncRNAs showing expression trend in discovery set of samples. (B) Relative expression of ADAMTS9‐AS2. (C) Relative expression of CTB‐92J24.3. (D) Relative expression of RP11‐295M3.4. (E) Relative expression of RP11‐490M8.1. (F) Relative expression of WDFY3‐AS2. (G) Relative expression of EPB41L4A‐AS1. (H) Relative expression of FAM83H‐AS1. (I) Relative expression of MIAT. (J) Relative expression of LINC01614. (K) Relative expression of ST8SIA6‐AS1. (L) Relative expression of CTB‐131K11.1. (M) Relative expression of RP11‐161M6.2. (B–M are relative expression levels of lncRNA evaluated in validation set of samples); (Wilcoxon sign rank test P‐value < 0.0001 = ****, P < 0.001 = *** and not indicated for nonsignificant candidates).